- Report
- March 2025
- 208 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- May 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- December 2024
- 84 Pages
Global
From €3336EUR$3,495USD£2,795GBP
- Report
- October 2024
- 187 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- August 2024
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- March 2025
- 94 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- May 2024
- 133 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- July 2024
- 187 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- December 2021
- 245 Pages
Global
From €2625EUR$2,750USD£2,199GBP
€5249EUR$5,500USD£4,398GBP
- Report
- September 2023
- 180 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- August 2022
- 119 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2022
- 200 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- August 2022
United States
From €1851EUR$1,940USD£1,551GBP
- Report
- August 2022
Global
From €1040EUR$1,090USD£872GBP
- Report
- March 2024
- 168 Pages
Global
€4767EUR$4,995USD£3,994GBP
- Report
- February 2022
- 87 Pages
Global
From €3200EUR$3,592USD£2,775GBP
- Report
- February 2024
- 91 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2022
- 35 Pages
Global
From €3340EUR$3,500USD£2,799GBP

The Hepatitis C Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat the Hepatitis C virus, a contagious virus that can cause liver damage. These drugs are typically administered orally or intravenously and can be used to treat both acute and chronic infections. The drugs are designed to reduce the amount of virus in the body, reduce the risk of liver damage, and improve the quality of life for those infected.
The Hepatitis C Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, and Janssen Pharmaceuticals. Other companies, such as Mylan, Cipla, and Natco Pharma, also offer treatments for the virus. Show Less Read more